A low individualized GH dose in young patients with childhood onset GH deficiency normalized serum IGF-I without significant deterioration in glucose tolerance

Clinical Endocrinology

Volumn 50, Issue 1, 1999, Pages 45-55

  Bülow, Birgitta ^a   Erfurth, Eva Marie ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; CORTISONE ACETATE; DESMOPRESSIN; ETHINYLESTRADIOL PLUS LEVONORGESTREL; GLUCOSE; HUMAN GROWTH HORMONE; INSULIN; LEVOTHYROXINE; MEDROXYPROGESTERONE ACETATE; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN C; TESTOSTERONE ENANTATE;

ADULT; ARTICLE; BODY FAT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG EFFICACY; FEMALE; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; GROWTH HORMONE DEFICIENCY; HORMONE BLOOD LEVEL; HORMONE RELEASE; HORMONE SUBSTITUTION; HUMAN; HYPOPITUITARISM; INTRAVENOUS DRUG ADMINISTRATION; LONG TERM CARE; MALE; ONSET AGE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; QUALITY OF LIFE; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; BLOOD GLUCOSE; BODY COMPOSITION; BODY MASS INDEX; DRUG ADMINISTRATION SCHEDULE; FEMALE; GLUCOSE TOLERANCE TEST; GROWTH HORMONE; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR I; MALE; QUALITY OF LIFE;

EID: 0032994246     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1999.00595.x     Document Type: Article

References (52)

1. Ashworth, L., Gibb, I. & Alberti, G.M.M. (1992) HemoCue: evaluation of a portable photometric system for determining glucose in whole blood. Clincial Chemistry, 38, 1479-1482.
2. Baxter, R.C. (1991) Insulin-like growth factor (IGF) binding proteins: the role of serum IGFBPs in regulating IGF availability. Acta Paediatrica Scandinavica (Suppl.), 372, 107-114.
3. Baxter, R.C. (1993) Circulating binding proteins for the insulinlike growth factors. Trends in Endocrinology and Metabolism, 4, 91-96.
4. Bengtsson, B.-Å., Edén, S., Lönn, L., Kvist, H., Stokland, A., Lindstedt, G., Bosaeus, I., Tölli, J., Sjöström, L. & Isaksson, O.G.P. (1993) Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. Journal of Clinical Endocrinology and Metabolism, 76, 309-317.
5. Beshyah, S.A., Henderson, A., Niththyananthan, R., Skinner, E., Anyaoku, V., Richmond, W., Sharp, P. & Johnston, D.G. (1995) The effects of short and long term growth hormone replacement therapy in hypopituitary adults on lipid metabolism and carbohydrate tolerance. Journal of Clinical Endocrinology and Metabolism, 80, 356-363.
6. Binnerts, A., Swart, G.R., Wilson, J.H.P., Hoogerbrugge, N., Pols, H.A.P., Birkenhager, J.C. & Lamberts, S.W.J. (1992) The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition. Clinical Endocrinology, 37, 79-87.
7. Brismar, K., Grill, V., Efendic, S. & Hall, K. (1991) The insulin-like growth factor binding protein-1 in low and high insulin responders before and during Dexamethasone treatment. Metabolism, 40, 728-732.
8. Bülow, B., Hagmar, L., Mikoczy, Z., Nordström, C.-H. & Erfurth, E.M. (1997) Increased cerebrovascular mortality in patients with hypopituitarism. Clinical Endocrinology, 46, 75-81.
9. Burman, P., Broman, J.E., Hetta, J., Wiklund, I., Erfurth, E.M., Hägg, E. & Karlsson, F.A. (1995) Quality of life in adults with growth hormone (GH) deficiency: response to treatment with recombinant human GH in a placebo-controlled 21-month trial. Journal of Clinical Endocrinology and Metabolism, 80, 3585-3590.
10. Burman, P., Johansson, A.G., Siegbahn, A., Vessby, B. & Karlsson, F.A. (1997) Growth hormone (GH) -deficient men are more responsive to GH replacement therapy than women. Journal of Clinical Endocrinology and Metabolism, 82, 550-555.
11. Cahill, G.F., Herrera, M.G., Morgan, A.P., Soeldner, J.S., Steinke, J., Levy, P.L., Reichard, G.A. & Kipnis, D.M. (1966) Hormone-fuel interrelationships during fasting. Journal of Clinical Investigation, 45, 1751-1767.
12. Chipman, J.J., Attanasio, A.F., Birkett, M.A., Bates, P.C., Webb, S. & Lamberts, S.W.J. (1997) The safety profile of GH replacement therapy in adults. Clinical Endocrinology, 46, 473-481.
13. Cotterill, A.M., Holly, J.M.P. & Wass, J.A.H. (1993) The regulation of insulin-like growth factor binding protein (IGFBP)-1 during prolonged fasting. Clinical Endocrinology, 39, 357-362.
14. De Boer, H., Blok, G.J., Popp-Snijders, C., Stuurman, L., Baxter, R.C. & van der Veen, E. (1996) Monitoring of growth hormone replacement therapy in adults, based on measurement of serum markers. Journal of Clinical Endocrionology and Metabolism, 81, 1371-1377.
15. De Boer, H., Blok, G.-J., Popp-Snijders, C. & van der Veen, E.A. (1994) Diagnosis of growth hormone deficiency in adults. Lancet, 343, 1645-1646.
16. De Boer, H., Blok, G.-J., Voerman, B., De Vries, P., Popp-Snijders, C. & van der Veen, E. (1995) The optimal growth hormone replacement dose in adults, derived from bioimpedance analysis. Journal of Clinical Endocrionology and Metabolism, 80, 2069-2076.
17. De Boer, H., Blok, G.J., Voerman, H.J., De Vries, P.M.J.M. & van der Veen, E.A. (1992) Body composition in adult growth hormone deficient men, assessed by anthropometry and bioimpedance analysis. Journal of Clinical Endocrionology and Metabolism, 75, 833-837.
18. Degerblad, M., Elgindy, N., Hall, K., Sjöberg, H.-E. & Thorén, M. (1992) Potent effect of recombinant growth hormone on bone mineral density and body composition in adults with panhypopituitarism. Acta Endocrinologica, 126, 387-393.
19. Diamond, M.P., Simonson, D.C. & DeFronzo, R.A. (1989) Menstrual cyclicity has a profound effect on glucose homeostasis. Fertility and Sterility, 52, 204-208.
20. Fowelin, J., Attvall, S., Lager, I. & Bengtsson, B.-Ä. (1993) Effects of treatment with recombinant human growth hormone on insulin sensitivity and glucose metabolism in adults with growth hormone deficiency. Metabolism, 42, 1443-1447.
21. Ganda, O.P., Day, J.L., Soeldner, J.S., Connon, J.J. & Gleason, R.E. (1978) Reproducibility and comparative analysis of repeated intravenous and oral glucose tolerance tests. Diabetes, 27, 715-725.
22. Gertler, M.M., Leetma, H.E., Koutrouby, R.J. & Johnson, E.D. (1975) The assement of insulin, glucose and lipids in ischemic thrombotic cerebrovascular disease. Stroke, 6, 77-84.
23. Ghigo, E., Aimaretti, G., Gianotti, L., Bellone, J., Arvat, E. & Camanni, F. (1996) New approach to the diagnosis of growth hormone deficiency. European Journal of Endocrinology, 134, 352-356.
24. Haffner, S.M., Karhapää, P., Mykkänen, L. & Laakso, M. (1994) Insulin resistance, body fat distribution and sex hormones in men. Diabetes, 43, 212-219.
25. Hew, F.L., Koschmann, M., Christopher, M., Rantzau, C., Vaag, A., Ward, G., Beck-Nielsen, H. & Alford, F. (1996) Insulin resistance in growth hormone-deficient adults: defects in glucose utilization and glycogen synthase activity. Journal of Clinical Endocrinology and Metabolism, 81, 555-564.
26. Hilding, A., Brismar, K., Degerblad, M., Thorén, M. & Hall, K. (1995) Altered relation between circulating levels of insulin-like growth factor-binding protein-I and insulin in growth hormone-deficient patients and insulin-dependent diabetic patients compared to that in healthy subjects. Journal of Clinical Endocrinology and Metabolism, 80, 2646-2652.
27. Holly, J.M.P., Biddlecombe, R.A., Dunger, D.B., Edge, J.A., Amiel, S.A., Howell, R., Chard, T., Rees, L.H. & Wass, J.A.H. (1988) Circadian variation of GH-independent IGF-binding protein in diabetes mellitus and its relationship to insulin. A new role for insulin? Clinical Endocrinology, 29, 667-675.
28. Holmes, S.J., McKenna, S.P., Doward, L.C., Hunt, S.M. & Shalet, S.M. (1995) Development of a questionnaire to assess the quality of life of adults with growth hormone deficiency. Endocrinology and Metabolism, 2, 63-69.
29. Hwu, C.-M., Kwok, C.F., Lai, T.-Y., Shih, K.-C., Lee, T.-S., Hsiao, L.-C., Lee, S.-H., Fang, V.S. & Ho, L.-T. (1997) Growth hormone (GH) replacement reduces total body fat and normalizes insulin sensitivity in GH-deficient adults: a report of one-year clinical experience. Journal of Clinical Endocrinology and Metabolism, 82, 3285-3292.
30. Iranmanesh, A., Lizarralde, G. & Veldhuis, J.D. (1991) Age and relative adiposity are specific negative determinants of the frequency and amplitude of growht hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. Journal of Clinical Endocrinology and Metabolism, 73, 1081-1088.
31. Johannsson, G., Bjarnason, R., Bramnert, M., Carlsson, L.M.S., Degerblad, M., Manhem, P., Rosén, T., Thorén, M. & Bengtsson, B.-Å. (1996) The individual responsiveness to growth hormone (GH) treatment in GH-deficient adults is dependent on the level of GH-binding protein, body mass index, age, and gender. Journal of Clinical Endocrinology and Metabolism, 81, 1575-1581.
32. Johannsson, G., Rosén, T. & Bengtsson, B.-Å. (1997) Individualized dose titration of growth hormone (GH) during GH replacement in hypopituitary adults. Clinical Endocrinology, 47, 571-581.
33. Johansson, J.-O., Fowelin, J., Landin, K., Lager, I. & Bengtsson, B.-Å. (1995) Growth hormone-deficient adults are insulin-resistant. Metabolism, 44, 1126-1129.
34. Jörgensen, J.O.L., Thuesen, L., Ingemann-Hansen, T., Pedersen, S.A., Jörgensen, J., Skakkebaek, N.E. & Christiansen, J.S. (1989) Beneficial effects of growth hormone treatment in GH-deficent adults. Lancet, i, 1221-1225.
35. Kalkhoff, R.K., Hartz, A.H., Rupley, D., Kissebah, A.H. & Kelber, S. (1983) Relationship of body fat distribution to blood pressure, carbohydrate tolerance, and plasma lipids in healthy obese women. Journal of Laboratory and Clinical Medicine, 101, 621-627.
36. Markussis, V., Beshyah, S.A., Fisher, C., Sharp, P., Nicolaides, A.N. & Johnston, D.G. (1992) Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults. Lancet, 340, 1188-1192.
37. McDonald, G.W., Fisher, G.F. & Burnham, C. (1965) Reproducibility of the oral glucose tolerance test. Diabetes, 14, 473-480.
38. McGauley, G.A. (1989) Quality of life assessment before and after growth hormone treatment in adults with growth hormone deficiency. Acta Paediatrica Scandinavica Suppl., 356, 70-72.
39. Möller, J., Jörgensen, J.O.L., Lauersen, T., Frystyk, J., Naeraa, R.W., Örskov, H. & Christiansen, J.S. (1993) Growth hormone dose regimens in adult GH deficiency: effects on biochemical growth markers and metabolic parameters. Clinical Endocrinology, 39, 403-408.
40. Peiris, A.N., Sothmann, M.S., Hoffman, R.G., Hennes, M.I., Wilson, C.R., Gustafson, A.B. & Kissebah, A.H. (1989) Adiposity, fat distribution, and cardiovascular risk. Annals of Internal Medicine, 110, 867-872.
41. Peters, N. & Hales, C.N. (1965) Plasma-insulin concentrations after myocardial infarction. Lancet, 1, 1144-1145.
42. Póvoa, G., Roovete, A. & Hall, K. (1984) Crossreaction of serum somatomedin-binding protein in a radioimmunoassay developed for somatomedin-binding protein isolated from human amniotic fluid. Acta Endocrinologica (Copenhagen), 107, 563-570.
43. Rosén, T. & Bengtsson, B.-Å. (1990) Premature mortality due to cardiovascular disease in hypopituitarism. Lancet, 336, 285-288.
44. Salomon, F., Cuneo, R.C., Hesp, R. & Sönksen, P.H. (1989) The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. New England Journal of Medicine, 321, 1797-1803.
45. Snyder, P.J. & Lawrence, D.A. (1980) Treatment of male hypogonadism with testosterone enanthate. Journal of Clinical Endocrinology and Metabolism, 51, 1335-1339.
46. Suikkari, A.-M., Koivisto, V.A., Rutanen, E.-M., Yki-Järvinen, H., Karonen, S.-L. & Seppälä, M. (1988) Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein. Journal of Clinical Endocrinology and Metabolism, 66, 266-272.
47. Thorell, J.I. & Larson, S.M. (1978) Radioimmunoassay and related techniques, pp. 205-211.CV Mosby Company, St Louis.
48. Weaver, J.U., Monson, J.P., Noonan, K., John, W.G., Edwards, A., Evans, K.A. & Cunningham, J. (1995) The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitiviy, and cardiovascular risk factors in hypopituitary adults. Journal of Clinical Endocrinology and Metabolism, 80, 153-159.
49. Welborn, T.A., Breckenridge, A., Rubenstein, A.H., Dollery, C.T. & Fraser, T.R. (1966) Serum-insulin in essential hypertension and in peripheral vascular disease. Lancet, 1, 1336-1337.
50. Whitehead, H.M., Boreham, C., McHrath, E.M., Sheridan, B., Kennedy, L., Atkinson, A.B. & Hadden, D.R. (1992) Growth hormone treatment of adults with growth hormone deficiency: results of a 13-month placebo controlled cross-over study. Clinical Endocrinology, 36, 45-52.
51. WHO (1985) Diabetes mellitus. Report of a study group. Technical Report Series, 727, 99.
52. Yki-Järvinen, H., Mäkimattila, S., Utriainen, T. & Rutanen, E.-M. (1995) Portal insulin concentrations rather than insulin sensitivity regualte serum sex hormone-binding globulin and insulin-like growth factor binding protein I in vivo. Journal of Clinical Endocrinology and Metabolism, 80, 3227-3232.